Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.The filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.This is a known potential adverse event addressed in the product labeling.
|
Healthcare professional (hcp) reported patient was injected with 1cc of juvéderm® ultra plus xc and experienced a ¿vascular occlusion." five days later, patient was treated with 2000-3000u of hyaluronidase, prednisone, keflex, topical bacitracin and steroids.Occlusion resolved.Approximately two months later, patient experienced pustules originating from treatment area.Event is ongoing.
|